Industry
Daniel Alain, Inc.
Total Trials
6
Recruiting
1
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
Phase 3
2(33.3%)
Early Phase 1
2(33.3%)
Phase 2
1(16.7%)
Phase 1
1(16.7%)
6Total
Phase 3(2)
Early Phase 1(2)
Phase 2(1)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT06648850Phase 2Not Yet Recruiting
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Role: collaborator
NCT07402330Early Phase 1Not Yet Recruiting
Pharmacokinetic Study of DA-020
Role: collaborator
NCT07397325Phase 1Not Yet Recruiting
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Role: collaborator
NCT07033845Early Phase 1Recruiting
Pharmacokinetic Study of Topical Phenylephrine
Role: collaborator
NCT06762548Phase 3Not Yet Recruiting
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Role: collaborator
NCT06501924Phase 3Not Yet Recruiting
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Role: collaborator
All 6 trials loaded